CytomX

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. 

CEO
Sean A. McCarthy
CEOSean A. McCarthy
Employees
121
Employees121
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2010
Founded2010
Employees
121
Employees121

CTMX Key Statistics

Market cap
940.37M
Market cap940.37M
Price-Earnings ratio
13.25
Price-Earnings ratio13.25
Dividend yield
Dividend yield
Average volume
4.09M
Average volume4.09M
High today
$5.87
High today$5.87
Low today
$5.40
Low today$5.40
Open price
$5.66
Open price$5.66
Volume
3.03M
Volume3.03M
52 Week high
$6.15
52 Week high$6.15
52 Week low
$0.40
52 Week low$0.40

Stock Snapshot

As of today, CytomX(CTMX) shares are valued at $5.60. The company's market cap stands at 940.37M, with a P/E ratio of 13.25.

As of 2026-01-24, CytomX(CTMX) stock has fluctuated between $5.40 and $5.87. The current price stands at $5.60, placing the stock +3.7% above today's low and -4.6% off the high.

The CytomX(CTMX)'s current trading volume is 3.03M, compared to an average daily volume of 4.09M.

In the last year, CytomX(CTMX) shares hit a 52-week high of $6.15 and a 52-week low of $0.40.

In the last year, CytomX(CTMX) shares hit a 52-week high of $6.15 and a 52-week low of $0.40.

CTMX News

TipRanks 4d
CytomX Therapeutics price target raised to $10 from $6.50 at Piper Sandler

Piper Sandler raised the firm’s price target on CytomX Therapeutics (CTMX) to $10 from $6.50 and keeps an Overweight rating on the shares. Initial Phase I data...

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.